WASHINGTON, DC & BOSTON, MA (Oct. 10, 2019) – The National Viral Hepatitis Roundtable (NVHR) and the Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) today launched an update to “Hepatitis C: State of Medicaid Access,” an interactive project grading all 50 state Medicaid programs, as well as the District of Columbia and Puerto Rico, according to access to curative treatments for hepatitis C, the nation’s deadliest infectious disease. NVHR, Harvard and other leading viral hepatitis advocates today also sent a letter to the U.S. Centers for Medicare and Medicaid Services (CMS) urging the agency to take action to end discriminatory state treatment restrictions, which, according to CMS guidance, violate federal Medicaid law.
Please join the National Viral Hepatitis Roundtable and the Center for Health Law and Policy Innovation at Harvard University to urge the Centers for Medicare and Medicaid Services to address illegal hepatitis C treatment prior authorization criteria in state Medicaid programs.
Read the letter here
Read the Press release here.